Aflac Incorporated (NYSE:AFL) Shares Acquired by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC raised its stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 12.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 25,451 shares of the financial services provider's stock after purchasing an additional 2,910 shares during the period. Motley Fool Asset Management LLC's holdings in Aflac were worth $2,633,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of AFL. Norges Bank acquired a new stake in shares of Aflac during the 4th quarter worth $349,699,000. Raymond James Financial Inc. acquired a new stake in Aflac during the fourth quarter worth about $163,409,000. Amundi increased its stake in Aflac by 81.1% during the fourth quarter. Amundi now owns 2,753,513 shares of the financial services provider's stock worth $285,181,000 after acquiring an additional 1,232,683 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Aflac by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider's stock worth $5,310,640,000 after purchasing an additional 653,275 shares during the period. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Aflac by 670.9% in the 4th quarter. Assenagon Asset Management S.A. now owns 556,576 shares of the financial services provider's stock valued at $57,572,000 after purchasing an additional 484,378 shares in the last quarter. Hedge funds and other institutional investors own 67.44% of the company's stock.

Insider Buying and Selling at Aflac

In related news, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now directly owns 49,962 shares in the company, valued at $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the transaction, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their position. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by company insiders.

Remove Ads

Aflac Stock Performance

Shares of NYSE:AFL traded up $5.68 during trading on Wednesday, hitting $105.45. 3,031,436 shares of the company traded hands, compared to its average volume of 2,151,576. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The business's fifty day moving average is $106.38 and its 200-day moving average is $107.48. The stock has a market capitalization of $57.56 billion, a price-to-earnings ratio of 10.98, a PEG ratio of 3.24 and a beta of 0.81. Aflac Incorporated has a one year low of $79.31 and a one year high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, equities analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

AFL has been the subject of a number of research analyst reports. Barclays dropped their target price on shares of Aflac from $98.00 to $95.00 and set an "underweight" rating for the company in a research report on Friday, February 7th. Keefe, Bruyette & Woods lowered their price target on Aflac from $107.00 to $104.00 and set a "market perform" rating for the company in a report on Wednesday, February 12th. JPMorgan Chase & Co. upped their target price on Aflac from $94.00 to $96.00 and gave the stock a "neutral" rating in a research report on Wednesday, April 2nd. Wells Fargo & Company decreased their price target on Aflac from $104.00 to $102.00 and set an "equal weight" rating for the company in a report on Wednesday, February 19th. Finally, Piper Sandler upped their target price on shares of Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Aflac presently has an average rating of "Hold" and an average target price of $104.29.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.